Company / Financials
CervoMed Inc. Financials
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$4.0M
FY2025 · -43.9% YoY
Net Income
-$27.0M
FY2025 · -1141.6% YoY
Profit Margin
-673.1%
FY2025 · net income / revenue
ROE
-148.0%
FY2025 · return on equity
Total Assets
$22.9M
FY2025
Total Debt
-
FY2025
Equity
$18.2M
FY2025
ROA
-117.9%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -5.07 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$4.0M-43.9% YoYNet Income HistoryProfit after all expenses and taxes-$27.0M-1141.6% YoYGross Profit HistoryRevenue minus cost of goods sold-Cost of Revenue HistoryDirect costs of producing goods and services sold-Operating Income HistoryProfit from core business operations before interest and taxes-$28.3M-262.2% YoYSG&A Expense HistorySelling, general, and administrative expenses$10.5M+60.8% YoYR&D Expense HistoryResearch and development spending$21.8M+158.5% YoYInterest Expense HistoryCost of borrowing and debt obligations-Income Tax HistoryTotal income tax expense$0EPS (Basic) HistoryBasic earnings per share-$2.02-146.3% YoY